VIR
Vir Biotechnology Inc
11.80$
+5.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5,904.9% | -642.9% | -194.0% | -2,531.6% | -7,205.0% | -708.2% | -2,576.4% | -9,902.7% | -69,820.8% | -40.4% | – | -3.8% | -110.4% | |
| 242.6% | 26.7% | 8.0% | 138.5% | 121.7% | 23.3% | 94.6% | 784.8% | 1,249.2% | 4.5% | – | 2.3% | 4.7% | |
| 1,021.0% | 168.4% | 42.1% | 720.7% | 701.6% | 128.0% | 463.7% | 1,025.6% | 4,731.7% | 35.2% | – | 10.2% | 23.2% | |
| -1,125.2% | -195.1% | -145.7% | -76.5% | 735.0% | -137.4% | 859.5% | -2,064.3% | -8,583.8% | -4.4% | – | 0.3% | -15.0% | |
| 140.7% | 9.1% | 3.3% | 21.7% | 99.0% | 19.5% | 53.7% | 209.1% | 132.1% | 7.0% | – | 0.2% | 1.9% | |
| -2,234.0% | -624.4% | 50.4% | 6,881.5% | 4,983.3% | 1,137.4% | 4,182.7% | 4,650.4% | 16,852.5% | 135.2% | – | -77.6% | -15.3% | |
| – | – | – | – | -1.7% | – | 0.0% | – | – | – | – | – | – | |
| 10.5% | 10.0% | 0.3% | 95.7% | 1.3% | 10.2% | 19.7% | 168.5% | 42.5% | 1.6% | – | 100.8% | 133.4% | |
| -8,140.2% | -1,253.6% | -143.3% | 4,447.6% | -2,221.1% | 439.3% | 1,626.0% | -5,083.8% | -52,926.3% | 96.5% | – | 19.5% | 7.7% | |
| -6,045.6% | -652.1% | -197.4% | -2,553.3% | -7,304.0% | -727.7% | -2,630.1% | -10,111.8% | -69,952.9% | -33.4% | – | -4.0% | -109.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.